Acura Pharmaceuticals Inc (ACUR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2011 | 09-2011 | 06-2011 | 03-2011 | 12-2010 | |
| Sales | 0 | 0 | 20,233 | 233 | 359 |
| Gross Profit | 0 | N/A | 20,233 | 233 | 359 |
| Operating Expenses | 1,847 | 2,147 | 2,871 | 3,067 | 3,296 |
| Operating Income | -1,847 | -2,147 | 17,362 | -2,834 | -2,937 |
| Other Income | 7 | 6 | 5 | -20 | 11 |
| Pre-tax Income | -1,840 | -2,141 | 17,367 | -2,854 | -2,926 |
| Income Tax | -194 | N/A | 338 | 3 | 1 |
| Net Income Continuous | -1,646 | -2,141 | 17,029 | -2,857 | -2,927 |
| Net Income | $-1,646 | $-2,141 | $17,029 | $-2,857 | $-2,927 |
| EPS Basic Total Ops | -0.15 | -0.25 | 1.80 | -0.30 | -0.30 |
| EPS Basic Continuous Ops | -0.18 | -0.22 | 1.80 | -0.30 | -0.31 |
| EPS Diluted Total Ops | -0.10 | -0.25 | 1.75 | -0.30 | -0.30 |
| EPS Diluted Continuous Ops | -0.16 | -0.22 | 1.77 | -0.30 | -0.31 |
| EBITDA(a) | $-1,815 | $-2,117 | $17,397 | $-2,800 | $-2,903 |